Movatterモバイル変換


[0]ホーム

URL:


SE0203817D0 - New composition - Google Patents

New composition

Info

Publication number
SE0203817D0
SE0203817D0SE0203817ASE0203817ASE0203817D0SE 0203817 D0SE0203817 D0SE 0203817D0SE 0203817 ASE0203817 ASE 0203817ASE 0203817 ASE0203817 ASE 0203817ASE 0203817 D0SE0203817 D0SE 0203817D0
Authority
SE
Sweden
Prior art keywords
nitrate
new composition
active substance
pharmaceutically active
administration
Prior art date
Application number
SE0203817A
Other languages
Swedish (sv)
Inventor
Jon Lundberg
Eddie Weitzberg
Original Assignee
Jon Lundberg
Eddie Weitzberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jon Lundberg, Eddie WeitzbergfiledCriticalJon Lundberg
Priority to SE0203817ApriorityCriticalpatent/SE0203817D0/en
Publication of SE0203817D0publicationCriticalpatent/SE0203817D0/en
Priority to PCT/SE2003/002052prioritypatent/WO2004056376A1/en
Priority to AU2003291600Aprioritypatent/AU2003291600A1/en

Links

Classifications

Landscapes

Abstract

The use of nitrate (NO3-) in pharmaceutical formulations, e.g. in combination with a pharmaceutically active substance has been found to prevent or alleviate known side effects, as well as enhance the effect of many pharmaceutically active substances without the need for modification of the active substance itself. The invention also presents methods of treatment, based on the administration of nitrate.
SE0203817A2002-12-202002-12-20 New compositionSE0203817D0 (en)

Priority Applications (3)

Application NumberPriority DateFiling DateTitle
SE0203817ASE0203817D0 (en)2002-12-202002-12-20 New composition
PCT/SE2003/002052WO2004056376A1 (en)2002-12-202003-12-19Pharmaceutical formulations containing nitrate
AU2003291600AAU2003291600A1 (en)2002-12-202003-12-19Pharmaceutical formulations containing nitrate

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
SE0203817ASE0203817D0 (en)2002-12-202002-12-20 New composition

Publications (1)

Publication NumberPublication Date
SE0203817D0true SE0203817D0 (en)2002-12-20

Family

ID=20289966

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SE0203817ASE0203817D0 (en)2002-12-202002-12-20 New composition

Country Status (3)

CountryLink
AU (1)AU2003291600A1 (en)
SE (1)SE0203817D0 (en)
WO (1)WO2004056376A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
EP2124638B1 (en)2007-02-262016-12-07HeartBeet Ltd.Performance enhancing composition and use thereof
US10842813B2 (en)2007-02-262020-11-24Heartbeet LtdCompositions of nitrates and methods of use thereof
US11759477B2 (en)2007-02-262023-09-19Heartbeet Ltd.Compositions of nitrates and methods of use thereof
US10821132B2 (en)2007-02-262020-11-03Heartbeet LtdCompositions of nitrates and methods of use thereof
CA2678097C (en)2007-02-262023-03-14Jon LundbergNew use of nitrites and nitrates and compositions containing these
US10835555B2 (en)2007-02-262020-11-17Heartbeet LtdCompositions of nitrates and methods of use thereof

Also Published As

Publication numberPublication date
WO2004056376A1 (en)2004-07-08
AU2003291600A1 (en)2004-07-14

Similar Documents

PublicationPublication DateTitle
NO20062504L (en) Compositions and dosage forms for improved absorption
BR0312573A (en) Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives
CY1118179T1 (en) PHARMACEUTICAL COMPOSITION
BG66093B1 (en)Controlled release compositions comprising nimesulide
BR0214343A (en) 11 - Beta - Hydroxy Steroid Dehydrogenase Inhibitors Type 1
DE60334773D1 (en) FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE SUBSTANCES
ATE401874T1 (en) ADMINISTRATION OF CAPSAICINOIDS
CY1111470T1 (en) NEW PHARMACEUTICAL COMPOSITIONS CONTAINING FLYVERSERIN POLYMORPH A
DK1654253T3 (en) Substituted 3-pyrrolidine indole derivatives
MY143795A (en)Tetrahydropyridoindole derivatives
DE602005021770D1 (en) INDOLE-1-YL-ACETIC DERIVATIVES
GB0222514D0 (en)Organic compounds
NO20061236L (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin D derivatives and parathyroid hoziiton
CY1109537T1 (en) Peptides and Peptide Derivatives, PREPARATION OF THESE ALSO USE THESE FOR THE PREPARATION OF THERAPEUTIC AND / OR PREVENTIVE ACTIVE ACTION
DK1781277T3 (en) Combination composition comprising Ibuprofen and Paracetamol
EA200501821A1 (en) PHARMACEUTICAL COMBINATION, CONTAINING MODAFINIL AND OTHER DRUG PREPARATION
SE0203817D0 (en) New composition
TW200503785A (en)Dosage form containing (S)-pantoprazole as active ingredient
SE0000303D0 (en) Novel compounds
ATE451340T1 (en) DEUTERATED CATECHOLAMINE DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DK1273301T3 (en) Pharmaceuticals based on active ingredients that can be used for illicit administration
EA200601015A1 (en) ORAL COMPOSITIONS OF DEOXYPEGANINE AND THEIR APPLICATION
ATE357220T1 (en) MODIFIED RELEASE PHARMACEUTICAL COMPOSITION
MXPA04006675A (en)Pharmaceutical composition comprising a glitazone and a 4-oxobutanoic acid, and the use thereof for treating diabetes.
DE50304524D1 (en) DRUGS INCLUDED SUBSTITUTED 2,5-DIAMINOMETHYL-1H-PYRROLE

[8]ページ先頭

©2009-2025 Movatter.jp